Efficacy of c-Met inhibitor for advanced prostate cancer

BACKGROUND: Aberrant expression of HGF/SF and its receptor, c-Met, often correlates with advanced prostate cancer. Our previous study showed that expression of c-Met in prostate cancer cells was increased after attenuation of androgen receptor (AR) signalling. This suggested that current androgen ab...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, William H, Zhu, Chunfang, Clark, Curtis, Christensen, James G, Sun, Zijie
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964640/
https://www.ncbi.nlm.nih.gov/pubmed/20946682
http://dx.doi.org/10.1186/1471-2407-10-556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964640/
https://www.ncbi.nlm.nih.gov/pubmed/20946682
http://dx.doi.org/10.1186/1471-2407-10-556

Ejemplares similares